Ribonucleosides
-
Subject Areas on Research
- Acadesine inhibits neutrophil CD11b up-regulation in vitro and during in vivo cardiopulmonary bypass.
- Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease.
- Aminoimidazole carboxamide ribonucleoside toxicity: a model for study of pyrimidine starvation.
- An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery.
- An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.
- Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
- Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.
- Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts.
- Dissociation between early recovery of regional function and purine nucleotide content in postischaemic myocardium in the conscious dog.
- Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
- Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.
- Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.
- Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.
- Predictors of contemporary coronary artery bypass grafting outcomes.
- S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
- Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair.
- Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).